United States · Platforms & data · Seeking Alpha
Marimed targets New York launch in H1 2027 with $4B market opportunity as record $44.2M quarter extends momentum
Detailed summary
MariMed posts record Q3 2026 revenue of $44.2 million, up 8.5% year over year, with $4.7 million adjusted EBITDA and $3.5 million operating cash flow.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (seekingalpha.com)
